Literature DB >> 19170692

Fibromyalgia comorbidity in primary headaches.

M de Tommaso1, M Sardaro, C Serpino, F Costantini, E Vecchio, M Pia Prudenzano, P Lamberti, P Livrea.   

Abstract

Fibromyalgia syndrome (FMS) is a chronic pain condition of unknown aetiology characterized by diffuse pain and tenderness at tender points. The aim of the study was to assess the prevalence and clinical features of FMS in the different forms of primary headaches, in a tertiary headache centre. Primary headache patients (n = 217) were selected and submitted to the Total Tenderness Score, anxiety and depression scales, Migraine Disability Assessment, allodynia questionnaire, Short Form 36 Health Survey and the Medical Outcomes Study-Sleep Scale. In patients with FMS, the Multidimensional Assessment of Fatigue, the Pain Visual Analog Scale, the Manual Tender Point Survey and the Fibromyalgia Impact Questionnaire were employed. FMS was present in 36.4% of patients and prevailed significantly in tension-type headache and in patients with higher headache frequency. Headache frequency, pericranial muscle tenderness, anxiety and sleep inadequacy were especially associated with FMS comorbidity. In the FMS patients, fatigue and pain at tender points were significantly correlated with headache frequency. FMS seems increasingly prevalent with increased headache frequency, for the facilitation of central sensitization phenomena favoured by anxiety and sleep disturbances.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19170692     DOI: 10.1111/j.1468-2982.2008.01754.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  35 in total

Review 1.  Worldwide epidemiology of fibromyalgia.

Authors:  Luiz Paulo Queiroz
Journal:  Curr Pain Headache Rep       Date:  2013-08

2.  Update on laser-evoked potential findings in fibromyalgia patients in light of clinical and skin biopsy features.

Authors:  Marina de Tommaso; Maria Nolano; Florenzo Iannone; Eleonora Vecchio; Katia Ricci; Marta Lorenzo; Marianna Delussi; Francesco Girolamo; Vito Lavolpe; Vincenzo Provitera; Annamaria Stancanelli; Giovanni Lapadula; Paolo Livrea
Journal:  J Neurol       Date:  2013-12-24       Impact factor: 4.849

Review 3.  The role of vitamin D in pathophysiology and treatment of fibromyalgia.

Authors:  Carlos A S Jesus; David Feder; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2013-08

Review 4.  Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders.

Authors:  Lindsay L Kindler; Robert M Bennett; Kim D Jones
Journal:  Pain Manag Nurs       Date:  2009-12-02       Impact factor: 1.929

5.  Nociceptive blink reflex habituation biofeedback in migraine.

Authors:  M de Tommaso; M Delussi
Journal:  Funct Neurol       Date:  2017 Jul/Sep

Review 6.  Tension-type headache and systemic medical disorders.

Authors:  Simona Sacco; Silvia Ricci; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2011-12

7.  Characteristics of referred muscle pain to the head from active trigger points in women with myofascial temporomandibular pain and fibromyalgia syndrome.

Authors:  Cristina Alonso-Blanco; César Fernández-de-Las-Peñas; Ana Isabel de-la-Llave-Rincón; Pedro Zarco-Moreno; Fernando Galán-Del-Río; Peter Svensson
Journal:  J Headache Pain       Date:  2012-08-31       Impact factor: 7.277

8.  Self-reported comorbid pains in severe headaches or migraines in a US national sample.

Authors:  Octavia Plesh; Sally H Adams; Stuart A Gansky
Journal:  Headache       Date:  2012-05-03       Impact factor: 5.887

Review 9.  Comorbidity in perimenstrual migraine.

Authors:  Marianna Nicodemo; Sabina Cevoli; Giulia Giannini; Pietro Cortelli
Journal:  Curr Pain Headache Rep       Date:  2012-10

10.  The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine.

Authors:  Sami Küçükşen; Emine Genç; Halim Yılmaz; Ali Sallı; İlknur Albayrak Gezer; Ali Yavuz Karahan; Ender Salbaş; Havva Turaç Cingöz; Ömer Nas; Hatice Uğurlu
Journal:  Clin Rheumatol       Date:  2013-02-27       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.